Owner Perlan Therapeutics, Inc.

Inventors Fang, Fang; Luo, Guang-Xiang; Kohlstaedt, Lori Allison; Charles, Catherine Helen

Agent Shelston IP

Pub. Number AU-A-2012207040

Parent 2009201466

Filing date 26 July 2012

Wipo publication date 16 August 2012

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/00 Drugs for disorders of the respiratory system

A61P 11/06 Drugs for disorders of the respiratory system

A61P 25/06 Drugs for disorders of the nervous system

A61P 27/16 Drugs for disorders of the senses

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 14/00 Peptides having more than 20 amino acids

C07K 14/47 Peptides having more than 20 amino acids

C07K 14/475 Peptides having more than 20 amino acids

C07K 14/705 Peptides having more than 20 amino acids

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 Hybrid peptides

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/00 Enzymes, e.g. ligases (6.)

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 21/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

A61K 38/00 Medicinal preparations containing peptides